surmount-1 tirzepatide weight loss non-diabetic 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO trial investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with obesity or overweight but without diabetes. Researchers SURPASS to SURMOUNT: The Tirzepatide

With a longer-lasting effect and the highest biological value among dietary proteins, undenatured whey protein isolate proves to offer a significant nutritional advantage

Zhao L, Zhu C, Lu M, Chen C, Nie X, Abudukerimu B, et al

Speak to a certified functional nutritionist to personalize your skin nutrition strategy, especially if you have chronic concerns like pigmentation or hormonal acne

LiLash At The Med Spa of North Georgia, we offer LiLash, a leading lash serum that helps you achieve longer, fuller, and healthier-looking lashes

Figure 1 IMDs should be suspected particularly in children presenting with combined endocrinopathies